The risk of cardiovascular-related events among patients with prostate cancer receiving ADT: are all drugs created equal?

Mon, 2019-11-18 16:21 -- Sharon Janssens

We are sorry, but your browser is out of date.

An additional plug-in or an upgrade of your browser is required to play this video.